Reagent kit, measurement kit, and measurement method
An object of the present invention is to provide a reagent kit, a measurement kit, and a measurement method for measuring serum amyloid A, which enable simple and rapid measurement of serum amyloid A by promoting dissociation of the serum amyloid A from HDL and carrying out an antigen-antibody reaction. According to the present invention, provided is a reagent kit for measuring serum amyloid A, including first particles having a label and modified with a first binding substance having a property of specifically binding to serum amyloid A, at least one nonionic surfactant having an HLB value of 17 to 20, which is defined by (inorganicity value/organicity value)×10, and a molecular weight of 1000 or less, and a buffer capable of adjusting a pH of a reaction solution to be in a range of 5.5 to 7.0 or a range of 8.5 to 9.0.
1 . A reagent kit for measuring serum amyloid A, comprising:
first particles having a label and modified with a first binding substance having a property of specifically binding to serum amyloid A;
at least one nonionic surfactant having a hydrophilic-lipophilic balance value of 17 to 20, which is defined by (inorganicity value/organicity value)×10, and a molecular weight of 1000 or less; and
a buffer adjusting a pH of a reaction solution to be in a range of 5.5 to 7.0 or a range of 8.5 to 9.0.
2 . The reagent kit according to claim 1 ,
wherein an average particle diameter of the first particles is in a range of 70 nm to 500 nm.
3 . The reagent kit according to claim 1 , further comprising:
second particles which are modified with a second binding substance having no property of specifically binding to serum amyloid A and do not have a label.
4 . The reagent kit according to claim 3 ,
wherein an average particle diameter of the second particles is in a range of 70 nm to 500 nm.
5 . The reagent kit according to claim 1 ,
wherein the label includes a fluorescent dye.
6 . The reagent kit according to claim 1 ,
wherein the serum amyloid A is serum amyloid A in cat serum or cat plasma.
7 . The reagent kit according to claim 1 ,
wherein the buffer is 2-(N-morpholino) ethanesulfonic acid or N,N-bis(2-hydroxyethyl)glycine.
8 . The reagent kit according to claim 1 ,
wherein the first binding substance is an antibody.
9 . A measurement kit for serum amyloid A, comprising:
the reagent kit according to claim 1 ; and
a substrate on which a first metal film is formed, and a third binding substance having a property of specifically binding to serum amyloid A or of specifically binding to the first binding substance is fixed to the first metal film.
10 . The measurement kit according to claim 9 ,
wherein a second metal film is further formed on the substrate and a fourth binding substance having a property of specifically binding to the first binding substance, but not having a property of binding to serum amyloid A is fixed to the second metal film.
11 . A measurement kit for serum amyloid A, comprising:
the reagent kit according to claim 2 ; and
a substrate on which a first metal film is formed, and a third binding substance having a property of specifically binding to serum amyloid A or of specifically binding to the first binding substance is fixed to the first metal film.
12 . A measurement kit for serum amyloid A, comprising:
the reagent kit according to claim 3 ; and
a substrate on which a first metal film is formed, and a third binding substance having a property of specifically binding to serum amyloid A or of specifically binding to the first binding substance is fixed to the first metal film.
13 . A measurement kit for serum amyloid A, comprising:
the reagent kit according to claim 4 ; and
a substrate on which a first metal film is formed, and a third binding substance having a property of specifically binding to serum amyloid A or of specifically binding to the first binding substance is fixed to the first metal film.
14 . A measurement kit for serum amyloid A, comprising:
the reagent kit according to claim 5 ; and
a substrate on which a first metal film is formed, and a third binding substance having a property of specifically binding to serum amyloid A or of specifically binding to the first binding substance is fixed to the first metal film.
15 . A measurement kit for serum amyloid A, comprising:
the reagent kit according to claim 6 ; and
a substrate on which a first metal film is formed, and a third binding substance having a property of specifically binding to serum amyloid A or of specifically binding to the first binding substance is fixed to the first metal film.
16 . A measurement kit for serum amyloid A, comprising:
the reagent kit according to claim 7 ; and
a substrate on which a first metal film is formed, and a third binding substance having a property of specifically binding to serum amyloid A or of specifically binding to the first binding substance is fixed to the first metal film.
17 . A measurement kit for serum amyloid A, comprising:
the reagent kit according to claim 8 ; and
a substrate on which a first metal film is formed, and a third binding substance having a property of specifically binding to serum amyloid A or of specifically binding to the first binding substance is fixed to the first metal film.
18 . A measurement method for serum amyloid A in a biological sample, the method comprising:
a step of preparing a mixed solution which contains a biological sample containing serum amyloid A, first particles having a label and modified with a first binding substance having a property of specifically binding to serum amyloid A, at least one nonionic surfactant having a hydrophilic-lipophilic balance value of 17 to 20, which is defined by (inorganicity value/organicity value)×10, and a molecular weight of 1000 or less, and a buffer adjusting a pH of a reaction solution to be in a range of 5.5 to 7.0 or a range of 8.5 to 9.0;
a step of adding the mixed solution to an injection port at one end of a substrate on which a first metal film on which a third binding substance having a property of specifically binding to serum amyloid A is fixed is formed;
a step of allowing the mixed solution to flow down onto the substrate; and
a step of acquiring information of the label on the first metal film.
19 . The measurement method for serum amyloid A according to claim 18 ,
wherein in a case where the mixed solution is prepared, the biological sample is diluted with physiological saline at a dilution ratio of 4 times to 100 times.